HK1060522A1 - Method for producing powdery formulations - Google Patents

Method for producing powdery formulations

Info

Publication number
HK1060522A1
HK1060522A1 HK04103581A HK04103581A HK1060522A1 HK 1060522 A1 HK1060522 A1 HK 1060522A1 HK 04103581 A HK04103581 A HK 04103581A HK 04103581 A HK04103581 A HK 04103581A HK 1060522 A1 HK1060522 A1 HK 1060522A1
Authority
HK
Hong Kong
Prior art keywords
producing powdery
powdery formulations
formulations
producing
powdery
Prior art date
Application number
HK04103581A
Other languages
English (en)
Inventor
Georg Bock
Michael Walz
Original Assignee
Boehringer Ingelheim And Rhein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1060522(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001138022 external-priority patent/DE10138022A1/de
Application filed by Boehringer Ingelheim And Rhein filed Critical Boehringer Ingelheim And Rhein
Publication of HK1060522A1 publication Critical patent/HK1060522A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
HK04103581A 2000-10-12 2004-05-20 Method for producing powdery formulations HK1060522A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
DE2001138022 DE10138022A1 (de) 2001-08-10 2001-08-10 Verfahren zur Herstellung von Pulverformulierungen
PCT/EP2001/011636 WO2002030390A2 (de) 2000-10-12 2001-10-09 Verfahren zur herstellung von pulverformulierungen

Publications (1)

Publication Number Publication Date
HK1060522A1 true HK1060522A1 (en) 2004-08-13

Family

ID=26007343

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103581A HK1060522A1 (en) 2000-10-12 2004-05-20 Method for producing powdery formulations

Country Status (40)

Country Link
US (2) US6585959B2 (xx)
EP (1) EP1326585B2 (xx)
JP (2) JP4986369B2 (xx)
KR (1) KR100849837B1 (xx)
CN (1) CN1269470C (xx)
AR (1) AR034166A1 (xx)
AT (1) ATE319422T1 (xx)
AU (2) AU2002218220B2 (xx)
BG (1) BG66194B1 (xx)
BR (1) BR0114316A (xx)
CA (1) CA2425005C (xx)
CY (1) CY1105037T1 (xx)
CZ (1) CZ300022B6 (xx)
DE (1) DE50109178D1 (xx)
DK (1) DK1326585T4 (xx)
EA (1) EA004689B1 (xx)
EE (1) EE05146B1 (xx)
EG (1) EG24478A (xx)
ES (1) ES2259046T5 (xx)
HK (1) HK1060522A1 (xx)
HR (1) HRP20030277B1 (xx)
HU (1) HU229512B1 (xx)
IL (2) IL154919A0 (xx)
ME (1) ME02762B (xx)
MX (1) MXPA03003219A (xx)
MY (1) MY155912A (xx)
NO (1) NO333719B1 (xx)
NZ (1) NZ525781A (xx)
PE (1) PE20020424A1 (xx)
PL (1) PL204733B1 (xx)
PT (1) PT1326585E (xx)
RS (1) RS50495B (xx)
SA (1) SA01220518B1 (xx)
SI (1) SI1326585T2 (xx)
SK (1) SK285841B6 (xx)
TW (1) TWI283180B (xx)
UA (1) UA75375C2 (xx)
UY (1) UY26960A1 (xx)
WO (1) WO2002030390A2 (xx)
ZA (1) ZA200301349B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE275391T1 (de) * 2000-10-12 2004-09-15 Boehringer Ingelheim Pharma Neue tiotropium-haltige inhalationspulver
US6443152B1 (en) * 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
WO2002096422A2 (en) * 2001-05-25 2002-12-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
CA2479919C (en) * 2002-04-04 2011-05-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US8273331B2 (en) * 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
JP4744876B2 (ja) * 2002-08-21 2011-08-10 ノートン・ヘルスケアー リミテッド 乾燥粉末吸入組成物の製造方法
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
ATE498394T1 (de) * 2003-09-02 2011-03-15 Norton Healthcare Ltd Verfahren zur herstellung eines medikaments
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
SG137859A1 (en) 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
UY28589A1 (es) 2003-11-03 2005-06-30 Boehringer Ingelheim Int Nuevas sales de tiotropio, procedimientos para su preparación , así como formulaciones medicamentosas que las contienen
PL1691783T3 (pl) * 2003-12-03 2010-05-31 Boehringer Ingelheim Int Inhalator suchego proszku ze wstępnym odmierzaniem do leków wrażliwych na wilgoć
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
EP1848444B1 (en) 2005-02-10 2016-11-09 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0507835D0 (en) * 2005-04-18 2005-05-25 Solexa Ltd Method and device for nucleic acid sequencing using a planar wave guide
JP5227790B2 (ja) 2005-05-02 2013-07-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
PL2264042T3 (pl) * 2007-07-27 2012-10-31 Cargill Inc Mikronizacja polioli
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
KR101584390B1 (ko) * 2008-07-24 2016-01-11 레르 리키드 쏘시에떼 아노님 뿌르 레？드 에렉스뿔라따시옹 데 프로세데 조르즈 클로드 전이 금속 함유 필름의 침착을 위한 헤테로렙틱 시클로펜타디에닐 전이 금속 전구체
TWI491416B (zh) * 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
CN104042322B (zh) 2009-10-27 2017-06-06 赫莱拉公司 具有可冷却的能量发射组件的递送装置
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
AU2010319477A1 (en) 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
EP2575786B1 (en) 2010-06-03 2017-11-15 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Process for dry powder formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US20180021256A1 (en) 2014-07-09 2018-01-25 Arven Ilac Sanayi Ve Ticaret A.S. Process for the preparation of formulations for inhalation
PT3175842T (pt) * 2015-12-03 2020-03-04 Tiefenbacher Alfred E Gmbh & Co Kg Processo de mistura de pó seco
WO2020013793A2 (en) * 2018-07-12 2020-01-16 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising dopamine agonists
WO2022146255A1 (en) * 2020-12-31 2022-07-07 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
BE891013A (fr) † 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
JPS60150823A (ja) * 1984-01-17 1985-08-08 Satake Eng Co Ltd 穀物混合装置
JPH0439388A (ja) * 1990-06-04 1992-02-10 Teijin Ltd 土砂と繊維状物との混合方法
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
JPH06198156A (ja) * 1993-01-06 1994-07-19 Nagasaki Pref Gov 噴霧積層混合器
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
EP1131059B1 (de) * 1998-11-13 2003-03-05 Jago Research Ag Trockenpulver zur inhalation
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ZA200301349B (en) 2004-06-30
SA01220518B1 (ar) 2006-12-10
EP1326585B1 (de) 2006-03-08
SK285841B6 (sk) 2007-09-06
USRE38912E1 (en) 2005-12-06
UY26960A1 (es) 2002-06-20
HRP20030277B1 (en) 2011-09-30
BR0114316A (pt) 2003-08-26
CA2425005C (en) 2008-08-05
HRP20030277A2 (en) 2005-02-28
HUP0301268A2 (hu) 2003-10-28
UA75375C2 (en) 2006-04-17
JP2004510806A (ja) 2004-04-08
CA2425005A1 (en) 2003-04-04
WO2002030390A2 (de) 2002-04-18
AU1822002A (en) 2002-04-22
DK1326585T3 (da) 2006-05-22
SI1326585T2 (sl) 2011-01-31
DE50109178D1 (de) 2006-05-04
NZ525781A (en) 2004-11-26
CZ300022B6 (cs) 2009-01-14
YU27403A (sh) 2006-03-03
MY155912A (en) 2015-12-15
HU229512B1 (en) 2014-01-28
MXPA03003219A (es) 2004-12-03
ES2259046T5 (es) 2011-02-28
IL154919A (en) 2011-01-31
NO20031692D0 (no) 2003-04-11
EE05146B1 (et) 2009-04-15
ES2259046T3 (es) 2006-09-16
KR100849837B1 (ko) 2008-08-01
TWI283180B (en) 2007-07-01
AU2002218220B2 (en) 2006-06-15
EA004689B1 (ru) 2004-06-24
SI1326585T1 (sl) 2006-06-30
HUP0301268A3 (en) 2005-05-30
CN1269470C (zh) 2006-08-16
IL154919A0 (en) 2003-10-31
BG107673A (bg) 2003-11-28
PE20020424A1 (es) 2002-07-02
AR034166A1 (es) 2004-02-04
DK1326585T4 (da) 2011-01-10
MEP42708A (en) 2011-02-10
ME02762B (me) 2011-05-10
EA200300429A1 (ru) 2003-10-30
NO20031692L (no) 2003-06-06
US20020106332A1 (en) 2002-08-08
PL204733B1 (pl) 2010-02-26
KR20030051706A (ko) 2003-06-25
JP4986369B2 (ja) 2012-07-25
NO333719B1 (no) 2013-09-02
US6585959B2 (en) 2003-07-01
JP2009197025A (ja) 2009-09-03
PT1326585E (pt) 2006-05-31
WO2002030390A3 (de) 2002-06-27
ATE319422T1 (de) 2006-03-15
CY1105037T1 (el) 2010-03-03
CN1469733A (zh) 2004-01-21
BG66194B1 (bg) 2012-01-31
EP1326585A2 (de) 2003-07-16
EP1326585B2 (de) 2010-09-29
RS50495B (sr) 2010-03-02
EG24478A (en) 2009-08-03
EE200300170A (et) 2003-06-16
SK4372003A3 (en) 2003-07-01
PL362511A1 (en) 2004-11-02

Similar Documents

Publication Publication Date Title
AU1822002A (en) Method for producing powdery formulations
AU2002218220A1 (en) Method for producing powdery formulations
HUP0302060A3 (en) Method for preparing compositions
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
GB0010957D0 (en) Compound & method
HK1044538A1 (en) Method for preparation citalopram
AU2001291882A1 (en) Method for producing polyisobutylphenols
HUP0300160A3 (en) Process for preparing (+)-cis-sertraline
PL361146A1 (en) Method for producing isocyanato-organosilanes
HUP0104405A3 (en) Process for preparing imidachlopid
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
IL150043A0 (en) Method for preparing bromodifluoroacetic compounds
AU4663601A (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU7265900A (en) Method for producing otoplastics
IL147804A0 (en) Method for producing 4-cyano-2-aminomethylthiazol
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU8444201A (en) Process for producing fluoroalkanol
IL147769A0 (en) Method for producing 2-aminomethyl-4-cyano-thiazol
AU2001272448A1 (en) Method for producing dna-arrays
HUP0301741A3 (en) Method for producing 4-bromine-aniline derivatives
AU2002218768A1 (en) Method for preparing (+)-biotine

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20211014